Biocept - Model EGFR -CE IVD - Target Selector Mutation Test Kit - Brochure

Biocept’s Target Selector^™ molecular assay kits detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded (FFPE) tissue gained from surgical biopsies as well as circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies.  The EGFR pathway can include mutations that are among the most frequently evaluated biomarkers for lung cancer.